←
Nephrology News & Issues5,999 posts
Nephrology News & Issues avatar

Nephrology News & Issues

@Nephronline

The content you need, when you need it.

◷ Joined September 2010▧ 1,102 Photos and videos
Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 17

Presented at #KidneyWk In a phase 2a trial, novel molecule HLX79/E-602 plus rituximab was associated with higher response rates vs. rituximab alone for adults with membranous nephropathy. Learn more about the data @GoHealio vist.ly/5t9p6

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 17

📣 FDA NEWS The FDA approved obinutuzumab for proteinuria remission for adults with primary membranous nephropathy at risk for disease progression. Data from the phase 3 MAJESTY clinical trial served as the basis for approval. Learn more @GoHealio vist.ly/5t95w

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 16

For soccer players, clinicians can 🔷Monitor athletes experiencing abnormal conditions for more than 3 days 🔷Help players develop a tailored hydration, electrolyte plan 🔷Promote heat precautions and adequate recovery after games Learn more #KidneyWk vist.ly/5sy9q

Post attachment
Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 13

In late October, the FDA granted accelerated approval to ravulizumab-cwvz for proteinuria reduction in adults with IgA nephropathy. Data from the phase 3 I CAN trial served as the basis for accelerated approval. Learn about it @GoHealio 🔽🔽 vist.ly/5smvw

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 12

Implementation of interventions and screenings could help provide mental health care for kidney stone formers, Jie Tang, MD, MPH, @BrownMedicine told @GoHealio. Learn more 👇 vist.ly/5sggw

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 11

“Clinicians should make every effort to proactively reschedule missed treatments, given the strong association between rescheduling and rates of makeup treatments,” Francesca Tentori, MD, MS, @DaVitaDoc told @GoHealio Learn more about the #KidneyWk data vist.ly/5sb77

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 10

“I think sibeprenlimab will be a big part of the treatment armamentarium that we have, because it does target the disease at its heart,” @DanaRizk1 told @GoHealio. Learn more about the two-year results of the VISIONARY trial 👇 vist.ly/5s62i

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 10

Deaths attributed to renal failure with substance-use disorder rose 14-fold between 1999 and 2024, particularly for patients aged 55 to 84 years, according to data presented at #KidneyWk Learn more @GoHealio vist.ly/5s5rm

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 9

In the phase 3 TELIGAN trial, telitacicept was associated with reduced proteinuria and stabilized kidney function at 2 years vs. placebo for adults with IgA nephropathy. Learn about the data @GoHealio 🔽🔽 vist.ly/5r297

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 9

For kidney transplant recipients, long-term data from the Transplant Pregnancy Registry International highlights the importance of ⭐ Stable graft function ⭐ Planning for conception ⭐ Contraceptive use ⭐ Pregnancy counseling Learn more @GoHealio vist.ly/5ry8w

Post attachment
Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 6

Key takeaways from the VISIONARY trial presented at #KidneyWk 🔷Sibeprenlimab-szsi was associated with preserved kidney function vs. placebo at 2 years 🔷Sibeprenlimab-szsi reduced risks for kidney function decline or kidney failure by 97% Learn more: vist.ly/5rqmp

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 6

“There was a point in time in my career when I didn’t really understand the terminology ‘meet patients where they are,’” Jeffrey Giullian, MD, MBA, said. He does now. Learn how @DaVitaDoc's community screenings meet patients in their neighborhoods. 👇 vist.ly/5rncb

Nephrology News & Issues avatar
Nephrology News & Issues@Nephronline·Nov 6

Data presented at #KidneyWk: ❌ High-dose cholecalciferol was not associated with improved survival vs. standard care for patients on dialysis 🔍 Mortality risks were lower for men and patients of “non-white” race in subgroup findings. Learn more: vist.ly/5rmqi